Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0), replacing the previous version (v3.1.0).SummaryDifference3%
- Check19 days agoChange DetectedUpdated terminology to Squamous cell carcinoma of the head and neck and bumped the revision to v3.1.0, reflecting a terminology update and new version. Earlier term Head and neck squamous cell carcinoma and revision v3.0.2 were removed.SummaryDifference0.6%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has updated its facility name and location details, adding specific references to various cancers and related resources, while removing some previous location terms and outdated references.SummaryDifference4%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.